Referral proformas improve compliance to national colorectal 2-week wait targets: Does this affect cancer detection rates?

Colorectal Disease

Volumn 14, Issue 11, 2012, Pages 1351-1356

  Jani, A ^a   Jenner, L ^a   Ma, F ^a   Dutton, S ^b   Stevens, R ^a   Sharma, R A ^a,c  

^a OXFORD UNIVERSITY HOSPITALS NHS FOUNDATION TRUST   (United Kingdom)

^b UNIVERSITY OF OXFORD   (United Kingdom)

^c UNIVERSITY OF OXFORD   (United Kingdom)

Author keywords

Audit; Cancer networks; Early detection

Indexed keywords

ARTICLE; CANCER DIAGNOSIS; COLORECTAL CANCER; HEALTH CARE ORGANIZATION; HUMAN; MEDICAL AUDIT; PATIENT COMPLIANCE; PATIENT REFERRAL; PRACTICE GUIDELINE; PRIMARY MEDICAL CARE; PRIORITY JOURNAL;

CLINICAL AUDIT; COLORECTAL NEOPLASMS; EARLY DETECTION OF CANCER; GREAT BRITAIN; GUIDELINE ADHERENCE; HUMANS; PRACTICE GUIDELINES AS TOPIC; PRIMARY HEALTH CARE; RECORDS AS TOPIC; REFERRAL AND CONSULTATION;

EID: 84867389781     PISSN: 14628910     EISSN: 14631318     Source Type: Journal    
DOI: 10.1111/j.1463-1318.2012.03010.x     Document Type: Article

References (15)

1. CancerStats: cancer Statistics for the UK: http://info.cancerresearchuk.org/cancerstats
2. Neal R, Allgar V, Ali N et al. Stage, survival and delays in lung colorectal, prostate and ovarian cancer: comparison between diagnostic routes. Br J Gen Pract 2007; 57: 212-9.
3. Chen Z, King W, Pearcey R, Kerba M, Mackillop W The relationship between waiting time for radiotherapy and clinical outcomes: a systematic review of the literature. Radiother Oncol 2008; 87: 3-16.
4. Mackillop W Killing time: the consequences of delays in radiotherapy. Radiother Oncol 2007; 84: 1-4.
5. National Institute for Health and Clinical Excellence. 2005 Referral Guidelines for Suspected Cancer. Clinical guideline 27. National Institute for Health and Clinical Excellence, London.
6. The NHS Cancer Plan: September 2000. Department of Health.
7. Thames Valley Cancer Network Introduction: http://www.tvcn.scnetworks.nhs.uk/data.asp?DataID=109
8. Atkin W, Edwards R, Wardle J et al. Design of a multicentre randomized trial to evaluate flexible sigmoidoscopy in colorectal cancer screening. J Med Screen 2001; 8: 137-44.
9. Atkin W, Edwards R, Krajl-Hans I et al. UK Flexible Sigmoidoscopy Trial Investigators Once-only flexible sigmoidoscopy screening in prevention of colorectal cancer: a multicentre randomised control trial. Lancet 2010; 375: 1624-33.
10. Morris E, Sandin F, Lambert P et al. A population-based comparison of the survival of patients with colorectal cancer in England, Norway and Sweden between 1996 and 2004. Gut 2011; Feb 8. [Epub ahead of print].
11. Coleman M, Forman D, Bryant H et al. Cancer survival in Australia, Canada, Denmark, Norway, Sweden and the UK, 1995-2007 (the International Cancer Benchmarking Partnership): an analysis of population-based cancer registry data. Lancet 2011; 377: 127-38.
12. Marshall T, Lancashire R, Sharp D et al. The diagnostic performance of scoring systems to identify symptomatic colorectal cancer compared to current referral guidance. Gut 2011; Feb 25 [Epub ahead of print].
13. Thorne K, Hutchings H, Elwyn G The effects of the two-week rule on the NHS colorectal cancer diagnostic services: a systematic literature review. BMC Health Services Research 2006; 6: 43.
14. Rai S, Kelly M. Prioritization of colorectal referrals: a review of the 2-week wait referral system. Colorectal Dis 2007; 9: 195-202.
15. Diagnosis and management of colorectal cancer: http://guidance.nice.org.uk/CG/Wave16/2